Mallinckrodt, Endo look to carve out brighter future through $6.7B merger
Mallinckrodt and Endo are merging in a cash and stock deal worth some $6.7 billion, the companies said Thursday. Under the agreement, Endo shareholders are slated to receive a total of $80 million in cash and own 49.9% of the combined company, while Mallinckrodt shareholders will have a 50.1% piece of the pie.
Mallinckrodt Pharmaceuticals and Endo have agreed to combine in a nearly $7bn deal after the pair emerged from bankruptcy processes linked to liabilities over the US opioid crisis.
Endo Inc. said Tuesday it has entered into an agreement to divest its international pharmaceuticals business to Knight ...
The Maryland Senate voted to allow a state board to extend its mandate for lowering prescription drug costs to all residents.
It took me 20 years to get a diagnosis of endometriosis - and I had to travel from Northern Ireland to England to get it.
Did you know that if you had your first symptom of endometriosis today, you likely wouldn’t receive a diagnosis until 2034?
After being diagnosed with endometriosis and PCOS in her 20s, naturopath, nutritionist and scientist Madison Dohnt made it ...
Q4 2024 Earnings Conference Call March 13, 2025 8:00 AM ETCompany ParticipantsLaure Park - Senior Vice President ...
EAST WHITELAND — Endo, a pharmaceutical company that has its global headquarters in Chester County, is being acquired by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback